Drug intelligence / Profile preview

neomycin sulfate + polymyxin b sulfate + bacitracin zinc + hydrocortisone

Development stage
Approved
Lead developer
Monarch Pharmaceuticals
Modality
Peptides, Small Molecules
Administration
Ophthalmic
01

Overview

**Neomycin sulfate + polymyxin B sulfate + bacitracin zinc + hydrocortisone** is a fixed-dose ophthalmic anti-infective and corticosteroid combination marketed as **Cortisporin Ophthalmic Ointment** and available in generic ophthalmic-ointment formulations. Hydrocortisone activates the glucocorticoid receptor to suppress ocular inflammation, while neomycin inhibits bacterial protein synthesis through the 30S ribosomal subunit, polymyxin B disrupts Gram-negative bacterial outer membranes by binding lipopolysaccharide, and bacitracin inhibits bacterial cell-wall synthesis by blocking undecaprenyl-pyrophosphate recycling. It is used for corticosteroid-responsive inflammatory conditions of the conjunctiva, cornea, and anterior ocular segment when bacterial infection is present or likely, including chronic anterior uveitis and corneal injury from chemical, thermal, or radiation burns or foreign bodies. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=3b00eb5c-dd98-467e-a883-04c37a8ecc42))

Brand names
Cortisporin
Other names
neomycin and polymyxin b sulfates, bacitracin zinc and hydrocortisone ophthalmic ointmentneomycin + polymyxin b + bacitracin + hydrocortisone ophthalmic
02

Targets

Lipid A phosphate (Lipid A phosphate groups)GR (Glucocorticoid receptor)UPP (Undecaprenyl pyrophosphate)30S A-site (Bacterial ribosomal 30S A-site)

Beyond the preview

Go deeper on neomycin sulfate + polymyxin b sulfate + bacitracin zinc + hydrocortisone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on neomycin sulfate + polymyxin b sulfate + bacitracin zinc + hydrocortisone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call